Clinical Trials Logo

Blood Coagulation clinical trials

View clinical trials related to Blood Coagulation.

Filter by:

NCT ID: NCT01422304 Completed - Clinical trials for Neuromuscular Blockade

Reversal of Neuromuscular Blockade With Sugammadex or Usual Care in Hip Fracture Surgery or Joint (Hip/Knee) Replacement (P07038)

Start date: October 12, 2011
Phase: Phase 3
Study type: Interventional

This study will assess the effect of reversal of neuromuscular blockade with sugammadex compared with reversal according to usual care (neostigmine or spontaneous reversal) on the incidence of post-surgical bleeding events and on coagulation parameters in participants undergoing hip fracture surgery or joint (hip/knee) replacement surgery with neuromuscular blockage induced by rocuronium or vecuronium.

NCT ID: NCT01195025 Completed - Blood Coagulation Clinical Trials

Volume Kinetics for Starch Solution and Acetated Ringers

Start date: August 2010
Phase: N/A
Study type: Interventional

Volume kinetics is a method mostly used, so far, to study the distribution and elimination of crystalloid solutions. Voluven (in Sweden the most commonly used colloid for replacement of bleeding during surgery) is poorly studied, though. Also, a recent study showed unexpected volume kinetics for a crystalloid solution when it was given after a colloid solution. The investigators aim to study the volume kinetics of crystalloids and colloids and also the combination of the two in more detail. The investigators will also compare the invasive hemoglobin measurements with measurements from a new non-invasive tool (Radical 7, from Masimo Inc.) which could help to make volume kinetics more practical for everyday use. Finally the investigators will also study the concentrations of a few coagulation factors to see if they can explain the variations in coagulability that has been described in earlier studies of infusion solutions.

NCT ID: NCT00775398 Completed - Blood Coagulation Clinical Trials

Observational Study Assessing the Impact of Exposure to THROMBIN-JMI® on Coagulation Parameters.

MOSAIC
Start date: November 2008
Phase: N/A
Study type: Observational

The purpose of this study is to assess the effect of possible exposure to THROMBIN JMI® on activated partial thromboplastin time (aPTT) at 48 hours post surgery in subjects with likelihood of prior exposure to THROMBIN JMI® within the past 4 years.